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Background: For the treatment of DM and prevention of acute and 
chronic complications, it is necessary that the patient achieve good 
glycemic control, which is possible through self-care actions that 
are based on changes in lifestyle and correct use of medications and 
insulins.
Objective: To describe self-care practices in the use of NPH and 
Regular Insulins in an ambulatory of the Unified Health System of 
Goiânia-GO-Brazil.
Methods: Cross-sectional study with type 2 diabetic patients. Data 
from nursing consultation sheets were collected during the period 
from October 2015 to March 2016. Patients whose insulin therapy data 
were complete were included. The data were analyzed in STATA 12.0, 
using descriptive statistics: means, absolute and relative frequency. 
The project was approved in the CEP of the HC/UFG.
Results: From 107 DM2 patients taking insulin, 57% were female and 
46% female, with a mean age of 56 years (± 11.3). As for comorbidities, 
64.7% were hypertensive, 41% had dyslipidemias, 18% had thyroid 
diseases. The mean values of fasting, postprandial and glycated hemo-
globin were respectively 219 mg/dl, 303 mg/dl and 9.8%. As for the 
use of insulin 80% applied without help and 17% needed another per-
son, being mostly elderly. As for sites, 45.9% apply only in one place, 
being: 16.7% in the arm, 30.0% in the abdomen, 13% in the legs and 
1% in the gluteus. In addition, 86.4% applied cold insulin and 35.4% 
kept it in the refrigerator door, 21.5% reused needles 1 to 2 days and 
71.8% discarded them in household trash.
Conclusion: The results showed that some care taken by diabetics 
is not consistent with the recommendations of the Brazilian Society 
of Diabetes (SBD, 2014) and the Ministry of Health (BRASIL, 2013). 
Despite the evolution of the practices regarding insulin therapy, prac-
tices such as material reuse, lack of rotation, inadequate preservation 
and disposal are still frequent. The health services need to invest in 
permanent education of professionals and actions to manage matters 
that allow better treatment to users.
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Introduction: Pregestational diabetes has been recognized as a risk 
factor for adverse pregnancy results. Our objective was to evaluate 
maternal outcomes in women with pregestational diabetes, either 
type 1 or type 2 diabetes.
Methods: We analyzed 220 women, 85 (39%) with type 1 diabetes and 
135 (61%) with type 2, attended in a specialized prenatal care facility. 
Preeclampsia and maternal hospital admission were the outcomes; 
type and duration of diabetes and maternal characteristics were stud-
ied as risk factors. Simple and multiple Poisson robust regression were 
performed with SPPS version 18; results are expressed as relative risk 
and 95% confidence interval (RR, 95% CI, p).
Results: The Table presents baseline maternal characteristics accord-
ing to the type of diabetes. Preeclampsia was diagnosed in 38.1% of 
type 1 women and in 24.8% of type 2 women (p = 0.056); hospital 
admission occurred in 78.3% of type 1 women and in 67.2% of type 
2 women (p = 0.111), with median duration of 14 days [interquartile 
interval 8-24]. Multivariable regression models showed that risk for 
preeclampsia was associated with gestational age at booking (1.032, 
1.003-1.062, p = 0.033), duration of diabetes (1.032, 1.001–1.064, 
p = 0.041) and chronic hypertension (2.100, 1.274–3.462, p = 0.004). 
Previous diagnosis of preeclampsia and type of diabetes did not 
impact in current preeclampsia risk. Hospital admission was associated 
with duration of diabetes (1.018, 1.006–1.030, p = 0.003), gestational 
age at booking (1.010, 1.001–1.020, p = 0.042) and the initial A1c test 
(1.110, 1.056–1.167, p < 0.001). Each 1% increase in the A1c test con-
ferred a 10% higher risk of hospital admission; each year of diabetes 
conferred a 3% increased risk for preeclampsia and a 2% risk for hos-
pital admission. Pregestational body mass index was found to be a 
protective factor for hospital admission (0.981, 0.965-0.998, p = 0.025): 
each lower kg/m2 reduced 2% the risk.
Conclusion: Preeclampsia and hospital admission were frequent 
events in pregnancies with previous diabetes and were related to 
duration, but not to the type of diabetes. Hospital admission was 
mainly related to poor glycemic control; and preeclampsia, to previous 
maternal hypertension. Management strategies for preeclampsia pre-
vention and intensive metabolic control should be firmly encouraged 
in this population (Fig. 1).
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Clinical case: AFG, 34 years old, with type 1 diabetes mellitus (DM) for 
21 years (prepregnancy HbA1c:8%), systemic arterial hypertension, 
proliferative diabetic retinopathy, neovascular glaucoma (left amauro-
sis), previous kidney transplanted, currentlly with ClCr:80 ml/min and 
proteinuria:630 mg/24 h, 2 previous stillbirths (32 and 34 weeks). In a 
new pregnancy, patient developed a hypertensive peak and decreased 
Fig. 1 See text for description
